Search results
Author(s):
Michael Hoebartner
,
Philipp Kiefer
,
Michael Andrew Borger
,
et al
Added:
3 years ago
Mitral valve regurgitation (MR) is frequently induced by degenerative mitral valve (MV) disease and leads to leaflet prolapse. Therefore, valve repair is a well-proven surgical technique with excellent long-term outcomes.1–5 The risk of declining left ventricle (LV) function or LV enlargement and the development of atrial fibrillation or severe pulmonary hypertension due to chronic volume…
View more
Maurizio Taramasso
Job title: Specialist in cardiac surgery
Author
Author(s):
Patricia Fonseca
,
Raphael Rosenhek
,
Vinayak Bapat
,
et al
Added:
3 years ago
Degenerative aortic stenosis (AS) is a chronic progressive valvular disease that affects approximately 1.4 % of individuals over 65 years and 4.6 % of patients older than 75 years in the US.1 While the prognosis of asymptomatic patients with severe AS is generally good, that of symptomatic patients is very poor, with an overall mortality of approximately 80 % at three years once the disease…
View more
New Trends and Developments in Patients with Severe Aortic Stenosis - Towards Optimal Treatment?
Author(s):
Martijn WA van Geldorp
,
Johanna JM Takkenberg
,
Ad JJC Bogers
,
et al
Added:
3 years ago
Article
Author(s):
Maxime Teisseire
,
Jérôme Caudron
,
Jean-Nicolas Dacher
Added:
3 years ago
In patients with severe aortic stenosis (aortic valve area <1cm2 or <0.6cm2/m2) and high surgical risk (haemodynamic instability or significant co-morbidities), surgical aortic valve replacement is often rejected and, unfortunately, balloon valvuloplasty cannot provide a sustained improvement. Percutaneous heart valve (PHV) implantation is an excellent alternative treatment in such cases…
View more
Foreword
Added:
3 years ago
Article
Author(s):
Firas Zahr
Added:
2 years ago
In this video interview, Dr Firas Zahr (OHSU Hospital, Portland, OR, US) outlines the 30-day outcomes of the Intrepid TMVR Early Feasibility Study, originally presented at TCT 2021. This was a prospective multicenter trial, designed to study the feasibility of the Intrepid TMVR System. At 30 days, findings show favourable haemodynamics and an improved NYHA class in patients with mitral…
View more
Author(s):
Dominik Wiedemann
,
Thomas Haberl
,
Julia Riebandt
,
et al
Added:
3 years ago
History of Mechanical Circulatory Support
The first reported clinical use of a left ventricular assist device (LVAD) was by Liotta and Crawford in 1963. Via a left thoracotomy, an intracorporeal pneumatically driven pump was implanted using left atrial inflow and descending thoracic aortic outflow. Despite the successful implantation, the patient died within a short period of time after the…
View more
EuroPCR 2022: ALIGN-EFS Finds 100% Procedural Success Rate Using JenaValve Trilogy in Pts With AS
Author(s):
Matti Adam
Added:
1 year ago
Video
Author(s):
Kendra J Grubb
Added:
5 months ago
TCT 23 - We are joined by Dr Kendra Grubb (Emory School of Medicine, Atlanta, GA, US) for a concise and insightful summary of the late-breaking trials that are expected to have an impact on interventional science concerning structural heart disease and clinical practice.
Trials covered in detail include:
PARTNER 3 & EVOLUT Low-Risk
ALIGN-AR
TENDYNE
APOLLO
TRILUMINATE
Recorded remotely…
View more